(Bortezomib plus lenalidomide/thalidomide)- vs (bortezomib or lenalidomide/thalidomide)-containing regimens as induction therapy in newly diagnosed multiple myeloma: a meta-analysis of randomized controlled trials

✍ Scribed by Wang, Anyou; Duan, Qiaohong; Liu, Xin; Ding, Kaiyang; Han, Yongsheng; Zhu, Weibo; Cai, Xiaoyan; Wu, Jingsheng; Sun, Zimin

• Book ID: 115508323
• Publisher: Springer
• Year: 2012
• Tongue: English
• Weight: 777 KB
• Volume: 91
• Category: Article
• ISSN: 0939-5555
• DOI: 10.1007/s00277-012-1520-4